Organization
Peapack
2 abstracts
Abstract
AGE AND RISK OF NSAID-INDUCED UPPER GASTROINTESTINAL (UGI) SYMPTOMS: ANALYSIS OF SUCCESS I, A DOUBLE BLIND, RANDOMIZED, CONTROLLED TRIAL IN 13,194 PATIENTS WITH OSTEOARTHRITIS (OA)Org: ARAMIS Postmarketing Surveillance Program, Stanford University Medical Center, Stanford, CA, Palo Alto University, Professor of Medicine, University of Illinois at Chicago,
Abstract
BASELINE RISK OF CARDIOVASCULAR DISORDERS AMONG NEW USERS OF IBUPROFEN, NAPROXEN, DICLOFENAC, AND CELECOXIBOrg: Global Health Outcomes, MERCK & CO., INC, Whitehouse Station, Pharmacia Corporation, Peapack, Outcomes Research Consortium, Pfizer,